ALT is activated in many of the remaining 10–15% of cancers, and is common in various cancers including osteosarcomas, several soft tissue sarcoma subtypes, and astrocytomas including pediatric glioblastoma (Bryan et al., 1997; Henson et al., 2005; Heaphy et al., 2011b). This evidence concerns the gene GPT and cancer.